Literature DB >> 26818489

Racial and Ethnic Disparities in Outpatient Substance Use Disorder Treatment Episode Completion for Different Substances.

Jeremy Mennis1, Gerald J Stahler2.   

Abstract

This study investigates how racial and ethnic disparities in treatment episode completion vary across different problem substances in an urban sample of 416,224 outpatient treatment discharges drawn from the 2011 U.S. Treatment Episode Dataset-Discharge (TEDS-D) data set. Fixed effects logistic regression is employed to test for the association of race and ethnicity with treatment episode completion for different substances of use while controlling for confounding demographic, socioeconomic, and geographic clustering factors. Results show that African Americans and Hispanics are less likely to complete a treatment episode than Whites, and that these disparities vary among users of different substances. For African Americans, this disparity is observed over all substances, but is particularly acute among users of alcohol and methamphetamine, substances for which African Americans generally have lower rates of use disorder as compared to Whites. For Hispanics, this disparity is driven primarily by users of heroin, for which Hispanics are only 75% as likely as Whites to complete a treatment episode. For users of cocaine and methamphetamine, there is no significant difference between Hispanics and Whites in the likelihood of treatment episode completion. These results contribute to emerging research on the mechanisms of substance use disorder treatment outcomes and highlight the need for culturally appropriate treatment programs to enhance treatment program retention and associated positive post-treatment outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African American; Disparities; Hispanic; Minority; Outpatient; Treatment completion

Mesh:

Year:  2015        PMID: 26818489     DOI: 10.1016/j.jsat.2015.12.007

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  34 in total

1.  Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.

Authors:  Melanie S Askari; Silvia S Martins; Pia M Mauro
Journal:  J Subst Abuse Treat       Date:  2020-05-11

2.  The growing transition from lifetime marijuana use to frequent use among 12th grade students: U.S. National data from 1976 to 2019.

Authors:  Yvonne M Terry-McElrath; Patrick M O'Malley; Lloyd D Johnston
Journal:  Drug Alcohol Depend       Date:  2020-05-18       Impact factor: 4.492

3.  Pharmacotherapy Prescribing to Patients with Concurrent Tobacco and Alcohol Use Disorder in a Large, Urban, Integrated Health System.

Authors:  Mat Kladney; Paul Joudrey; Chinazo O Cunningham; Marcus A Bachhuber
Journal:  J Gen Intern Med       Date:  2019-06       Impact factor: 5.128

4.  Until I get off parole … then I can swim in it if I want to: Facilitators of and barriers to drug use among formerly incarcerated Black drug offenders.

Authors:  Rahma Mkuu; Tawandra L Rowell-Cunsolo; Idethia Shevon Harvey
Journal:  J Ethn Subst Abuse       Date:  2017-06-30       Impact factor: 1.507

5.  Disparities in the Treatment of Substance Use Disorders: Does Where You Live Matter?

Authors:  Andrea Acevedo; Lee Panas; Deborah Garnick; Dolores Acevedo-Garcia; Jennifer Miles; Grant Ritter; Kevin Campbell
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

6.  Does change in readiness influence retention among African American women and men in substance abuse treatment?

Authors:  LaTrice Montgomery; A Kathleen Burlew; Jeffrey E Korte
Journal:  J Ethn Subst Abuse       Date:  2017-04-03       Impact factor: 1.507

7.  Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.

Authors:  Ryan Cook; Brendan Quinn; Keith Heinzerling; Steve Shoptaw
Journal:  Addiction       Date:  2017-02-16       Impact factor: 6.526

8.  Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients.

Authors:  Julie R Gaither; Kirsha Gordon; Stephen Crystal; E Jennifer Edelman; Robert D Kerns; Amy C Justice; David A Fiellin; William C Becker
Journal:  Drug Alcohol Depend       Date:  2018-08-06       Impact factor: 4.492

9.  Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.

Authors:  Danelle Stevens-Watkins
Journal:  Drug Alcohol Rev       Date:  2020-04-12

10.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.